Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Study Of The Safety Of Pneumococcal 13-valent Conjugate Vaccine (Prevenar 13) In The Philippines: A Post Marketing Surveillance Study

NCT01396434 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01396434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01396434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Study Of The Safety Of Pneumococcal 13-valent Conjugate Vaccine (Prevenar 13) In The Philippines: A Post Marketing Surveillance Study
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
May 31, 2014
Enrollment
3,006 (actual)
Sites
119

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal disease